Key PK parameters: K{el}, t{1/2}, F, V, CL; determined after a single dose.
Steady state: drug entering plasma equals clearance from plasma.
Therapeutic window: Plasma drug concentration between MEC and MTC.
Repeat oral administration & Constant rate IV infusion.
Predict Desired Css and Time to reach Css.
CSS = \frac{MDR}{CL}; MDR = maintenance dose rate.
Time to steady state: 3-5 half-lives.
Loading dose (DL): DL = Css \times V
CSS = \frac{F \times MDR}{CL}, F = absolute oral bioavailability.
Dosing interval (\tau) determines concentration variation between C{max ss} and C{min ss}.
C*{max} = \frac{Dose \times F}{V}
C{max ss} = \frac{F \cdot Dose}{V \cdot (1-e^{-K{el} \cdot \tau})}
C{min ss} = C{max ss} \cdot e^{-K[el} \cdot \tau}
Css = mean : of : C{min ss} : and : C{max ss}
t[1/2} < 30 min: difficult to maintain therapeutic concentrations.
t[1/2} 30 min - 8 h: dosing based on therapeutic window and convenience.
t[1/2} 8 h - 24 h: dose every half-life.
t[1/2} > 24 h: once per day or several days dosing feasible, but delayed Css.
Pharmacists select from manufacturer supplies, applying dosing principles.
Drug strengths affect Css, and dosing period impacts drug concentrations.
t[1/2}: time to reach steady state.
CL: concentration at steady state (Css).
V: loading dose and first oral dose.
F: with CL, Css following oral dosing.
K{el}: variability in concentrations; C{max} relative to therapeutic window.
Balances t[1/2}, therapeutic window, drug concentration variability, time to steady state, and dosing period convenience.